InvestorsHub Logo
Followers 1
Posts 193
Boards Moderated 0
Alias Born 09/30/2013

Re: infamous post# 690

Friday, 03/31/2017 4:13:06 PM

Friday, March 31, 2017 4:13:06 PM

Post# of 1724
People were anticipating a buyout by Novartis, AstraZeneca, or Lilly for somewhere in the neighborhood of $1-3 billion, making the shares worth $30+ each. Instead, they are merging with this new company Dare Biosciences and they sold off their two cancer drugs to someone and the IP for their trademark platform to Novartis for under $8 million total.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DARE News